Commonwealth Equity Services, Inc - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 41 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Commonwealth Equity Services, Inc ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2016$4,000
-75.0%
44,720
+2.8%
0.00%
Q2 2016$16,000
-5.9%
43,5000.0%0.00%
Q1 2016$17,0000.0%43,500
+2.4%
0.00%
Q4 2015$17,000
-29.2%
42,5000.0%0.00%
Q3 2015$24,000
-46.7%
42,500
-48.5%
0.00%
Q2 2015$45,000
-31.8%
82,500
+2.5%
0.00%
-100.0%
Q1 2015$66,000
+3.1%
80,5000.0%0.00%0.0%
Q4 2014$64,000
-22.9%
80,500
-1.2%
0.00%0.0%
Q3 2014$83,000
+18.6%
81,5000.0%0.00%0.0%
Q2 2014$70,00081,5000.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q3 2016
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$8,5000.00%
LEE DANNER & BASS INC 50,000$40.00%
LBMC INVESTMENT ADVISORS, LLC 22,000$1,7160.00%
Atlas Wealth LLC 26,620$2,2490.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,6900.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders